A Study of GC203 TIL in Advanced Solid Tumors (NF)

Clinical trial NCT07256756 · RECRUITING

Trial details

NCT number: NCT07256756
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors, Adult

Start date: 2026-01-30
Primary completion: 2026-11-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.